DiaMedica Therapeutics (DMAC) Inventory (2021 - 2023)

DiaMedica Therapeutics has reported Inventory for 3 years, with the latest figure at $317000.0 in Q4 2023.

• For the quarter ending Q4 2023, Inventory rose 654.76% year-over-year to $317000.0; the trailing twelve-month figure through Dec 2023 stood at $317000.0 (up 654.76% YoY), and the FY2023 full-year result was $317000.0, up 654.76% from the prior year.
• Inventory for Q4 2023 stood at $317000.0, down from $715000.0 in the prior quarter.
• The five-year high for Inventory was $715000.0 in Q3 2023, with the low at $42000.0 in Q4 2022.
• Historically, Inventory has averaged $223000.0 across 3 years, with a median of $102500.0 in 2021.
• Annual changes were most pronounced in 2022 — Inventory plunged 62.83% — and 2023, when it soared 654.76%.
• DiaMedica Therapeutics' Inventory stood at $113000.0 in 2021, then sank by 62.83% to $42000.0 in 2022, then soared by 654.76% to $317000.0 in 2023.
• The last three Inventory figures came in at $317000.0 (Q4 2023), $715000.0 (Q3 2023), and $59000.0 (Q2 2023), per Business Quant data.